Published in PLoS One on August 03, 2010
Functions of S100 proteins. Curr Mol Med (2013) 2.43
Peripheral immune cell gene expression changes in advanced non-small cell lung cancer patients treated with first line combination chemotherapy. PLoS One (2013) 0.85
Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling. Breast Cancer Res Treat (2013) 0.85
Post-operative recurrent trachomatous trichiasis is associated with increased conjunctival expression of S100A7 (psoriasin). PLoS Negl Trop Dis (2012) 0.83
TGFβ loss activates ADAMTS-1-mediated EGF-dependent invasion in a model of esophageal cell invasion. Exp Cell Res (2014) 0.82
Expression of human protein S100A7 (psoriasin), preparation of antibody and application to human larynx squamous cell carcinoma. BMC Res Notes (2011) 0.82
Establishment of field change by expression of cytokeratins 8/18, 19, and MMP-9 in an apparently normal oral mucosa adjacent to squamous cell carcinoma: A immunohistochemical study. J Oral Maxillofac Pathol (2012) 0.79
Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis. BMC Cancer (2014) 0.78
The Characteristics and Function of S100A7 Induction in Squamous Cell Carcinoma: Heterogeneity, Promotion of Cell Proliferation and Suppression of Differentiation. PLoS One (2015) 0.78
S100A7 induction is repressed by YAP via the Hippo pathway in A431 cells. Oncotarget (2016) 0.77
Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer. Oncogenesis (2015) 0.76
New insight into benign tumours of major salivary glands by proteomic approach. PLoS One (2013) 0.76
From Normal Skin to Squamous Cell Carcinoma: A Quest for Novel Biomarkers. Dis Markers (2016) 0.76
Psoriasin promotes invasion, aggregation and survival of pancreatic cancer cells; association with disease progression. Int J Oncol (2017) 0.75
The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma. PLoS One (2016) 0.75
Proteomic Characterization Reveals a Molecular Portrait of Nasopharyngeal Carcinoma Differentiation. J Cancer (2017) 0.75
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med (2006) 13.74
S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol (2001) 5.29
Oral cancer and precancerous lesions. CA Cancer J Clin (2002) 4.76
Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med (2007) 4.72
Intracellular and extracellular roles of S100 proteins. Microsc Res Tech (2003) 3.70
S100 proteins: structure, functions and pathology. Front Biosci (2002) 3.28
Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer (2008) 2.98
Profiling early head and neck cancer. Nat Rev Cancer (2005) 2.62
Calcium-dependent and -independent interactions of the S100 protein family. Biochem J (2006) 2.62
S100 proteins in the epidermis. J Invest Dermatol (2004) 2.32
Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J Invest Dermatol (1991) 1.99
Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res (2002) 1.81
Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry. Mol Cell Proteomics (2008) 1.76
Activation of Ras/Erk pathway by a novel MET-interacting protein RanBPM. J Biol Chem (2002) 1.62
Psoriasin: a novel chemotactic protein. J Invest Dermatol (1996) 1.59
S100 protein subcellular localization during epidermal differentiation and psoriasis. J Histochem Cytochem (2003) 1.58
Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol (1999) 1.56
The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. J Biol Chem (2005) 1.44
Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J Urol (1996) 1.42
Identification of differentially expressed genes in oral squamous cell carcinoma. Mol Carcinog (2005) 1.36
Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma. Cancer Res (1996) 1.31
Psoriasin expression in mammary epithelial cells in vitro and in vivo. Cancer Res (2002) 1.29
Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer. Clin Cancer Res (2003) 1.23
Psoriasin (S100A7). Int J Biochem Cell Biol (1998) 1.20
Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy? Oral Oncol (2004) 1.17
iTRAQ-multidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy. J Proteome Res (2009) 1.16
Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours. J Cancer Res Clin Oncol (2006) 1.15
S100A7 and the progression of breast cancer. Breast Cancer Res (2004) 1.14
S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer. Oncogene (2010) 1.09
Differential expression of S100 gene family in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol (2004) 1.06
Psoriasin (S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features. Oral Oncol (2009) 1.05
Reciprocal negative regulation between S100A7/psoriasin and beta-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity. Oncogene (2008) 1.05
Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas. Thorax (2008) 1.03
Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma. Int J Cancer (2009) 1.03
Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry. J Proteome Res (2008) 1.00
A characteristic subset of psoriasis-associated genes is induced by oncostatin-M in reconstituted epidermis. J Invest Dermatol (2006) 1.00
Identification of genes and molecular pathways involved in the progression of premalignant oral epithelia. Mol Cancer Ther (2005) 0.98
Expression profile of the S100 gene family members in oral squamous cell carcinomas. J Oral Pathol Med (2008) 0.95
Identification and validation of S100A7 associated with lung squamous cell carcinoma metastasis to brain. Lung Cancer (2007) 0.95
Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis. BMC Cancer (2005) 0.92
S100A4 regulates E-cadherin expression in oral squamous cell carcinoma. Cancer Lett (2005) 0.92
Clinical, pathological, cellular and molecular lesions caused by oral smokeless tobacco--a review. J Oral Pathol Med (2007) 0.90
Correlation of S100A4 expression with invasion and metastasis in oral squamous cell carcinoma. Oral Oncol (2004) 0.90
S100A2, a potential marker for early recurrence in early-stage oral cancer. Oral Oncol (2005) 0.88
Detection of psoriasin/S100A7 in the sera of patients with psoriasis. Br J Dermatol (2008) 0.85
Psoriasin is aberrantly expressed in human breast cancer and is related to clinical outcomes. Int J Oncol (2004) 0.84
S100A2 expression as a predictive marker for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral cavity. Oncol Rep (2005) 0.84
Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia. Mol Oncol (2007) 0.84
Identification and characterization of binding sites on S100A7, a participant in cancer and inflammation pathways. Biochemistry (2009) 0.80
Metastasis of squamous cell carcinoma of the oral tongue is associated with down-regulation of epidermal fatty acid binding protein (E-FABP). Oral Oncol (2006) 0.80
Clinical significance of phosphatidyl inositol synthase overexpression in oral cancer. BMC Cancer (2010) 0.79
Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21
High-definition macromolecular composition of yeast RNA-processing complexes. Mol Cell (2004) 4.18
Malignant peripheral nerve sheath tumors (MPNST)--clinicopathological study and treatment outcome of twenty-four cases. World J Surg Oncol (2006) 2.58
Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study. Radiother Oncol (2004) 2.25
Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J Proteome Res (2005) 2.22
Microarray analyses of gene expression during the Tetrahymena thermophila life cycle. PLoS One (2009) 2.11
Study of an RNA helicase implicates small RNA-noncoding RNA interactions in programmed DNA elimination in Tetrahymena. Genes Dev (2008) 1.82
Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry. Mol Cell Proteomics (2008) 1.76
Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance. Mol Cell Proteomics (2012) 1.72
Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study. J Clin Oncol (2010) 1.64
Problems with co-funding in Canada. Science (2005) 1.48
Phosphorylation motifs regulating the stability and function of myocyte enhancer factor 2A. J Biol Chem (2003) 1.44
Robust method for proteome analysis by MS/MS using an entire translated genome: demonstration on the ciliome of Tetrahymena thermophila. J Proteome Res (2005) 1.42
Multiple reaction monitoring of mTRAQ-labeled peptides enables absolute quantification of endogenous levels of a potential cancer marker in cancerous and normal endometrial tissues. J Proteome Res (2008) 1.42
Inhalable microparticles containing large payload of anti-tuberculosis drugs. Eur J Pharm Sci (2007) 1.39
Identification of differentially expressed genes in oral squamous cell carcinoma. Mol Carcinog (2005) 1.36
Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast. BMC Cancer (2009) 1.29
Production of multiple xylanolytic and cellulolytic enzymes by thermophilic fungus Myceliophthora sp. IMI 387099. Bioresour Technol (2006) 1.27
KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses. Int J Cancer (2010) 1.26
Efficiency of nano-electrospray ionization. J Am Soc Mass Spectrom (2005) 1.25
The Tetrahymena argonaute-binding protein Giw1p directs a mature argonaute-siRNA complex to the nucleus. Cell (2010) 1.25
Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry. Mol Cell Proteomics (2007) 1.25
Links between DNA double strand break repair and breast cancer: accumulating evidence from both familial and nonfamilial cases. Cancer Lett (2006) 1.21
An improved method for RNA isolation and cDNA library construction from immature seeds of Jatropha curcas L. BMC Res Notes (2010) 1.21
Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Life Sci (2007) 1.20
Protein kinase A represses skeletal myogenesis by targeting myocyte enhancer factor 2D. Mol Cell Biol (2008) 1.18
Curcumin down regulates smokeless tobacco-induced NF-kappaB activation and COX-2 expression in human oral premalignant and cancer cells. Toxicology (2006) 1.18
Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients. Life Sci (2007) 1.17
68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma. J Nucl Med (2013) 1.17
Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma. Head Neck Oncol (2009) 1.16
iTRAQ-multidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy. J Proteome Res (2009) 1.16
Absolute quantification of potential cancer markers in clinical tissue homogenates using multiple reaction monitoring on a hybrid triple quadrupole/linear ion trap tandem mass spectrometer. Anal Chem (2009) 1.14
Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1. Cancer Res (2008) 1.14
Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma. Oncotarget (2014) 1.11
The Tetrahymena thermophila phagosome proteome. Eukaryot Cell (2006) 1.11
Gaseous bradykinin and its singly, doubly, and triply protonated forms: a first-principles study. J Phys Chem B (2006) 1.10
Over-expression of 14-3-3zeta is an early event in oral cancer. BMC Cancer (2007) 1.09
A prospective randomized trial comparing harmonic scalpel versus electrocautery for pectoralis major myocutaneous flap dissection. Plast Reconstr Surg (2005) 1.08
MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma. Oncology (2005) 1.07
Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer. Breast Cancer Res Treat (2006) 1.06
Wnt signaling pathway in invasive ductal carcinoma of the breast: relationship between beta-catenin, dishevelled and cyclin D1 expression. Oncology (2008) 1.06
Skeletal and dentoalveolar effects of Twin-block and bionator appliances in the treatment of Class II malocclusion: a comparative study. Am J Orthod Dentofacial Orthop (2006) 1.05
Ion mobility spectrometer with radial collisional focusing. Anal Chem (2005) 1.04
Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients. Life Sci (2010) 1.04
Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma. Int J Cancer (2009) 1.03
Exploring the mitochondrial proteome of the ciliate protozoon Tetrahymena thermophila: direct analysis by tandem mass spectrometry. J Mol Biol (2007) 1.03
Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast. Life Sci (2008) 1.03
mTRAQ-based quantification of potential endometrial carcinoma biomarkers from archived formalin-fixed paraffin-embedded tissues. Proteomics (2010) 1.02
Clinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression. PLoS One (2013) 1.02
Angiogenesis in cutaneous melanoma: pathogenesis and clinical implications. Microsc Res Tech (2003) 1.02
Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis. Clin Cancer Res (2005) 1.01
Diversity of penicillin-binding proteins. Resistance factor FmtA of Staphylococcus aureus. J Biol Chem (2007) 1.01
Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins. J Breast Cancer (2013) 1.01
Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry. J Proteome Res (2008) 1.00
Orthodontic treatment of impacted anterior teeth due to odontomas: a report of two cases. J Clin Pediatr Dent (2004) 1.00
Nuclear and cytoplasmic accumulation of Ep-ICD is frequently detected in human epithelial cancers. PLoS One (2010) 1.00
A phase II study of gemcitabine and oxaliplatin (Oxigem) in unresectable gall bladder cancer. Cancer Chemother Pharmacol (2009) 0.99
Stromelysin-2 overexpression in human esophageal squamous cell carcinoma: potential clinical implications. Cancer Detect Prev (2002) 0.99
Protein expression profiling of endometrial malignancies reveals a new tumor marker: chaperonin 10. J Proteome Res (2004) 0.99
Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling. Chem Biol Interact (2009) 0.99
S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia. Int J Cancer (2013) 0.99
Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers. Proteomics (2011) 0.98
Detection of RASSF1A and RARbeta hypermethylation in serum DNA from breast cancer patients. Epigenetics (2006) 0.97
Two GW repeat proteins interact with Tetrahymena thermophila argonaute and promote genome rearrangement. Mol Cell Biol (2009) 0.97
Identification of secreted proteins during skeletal muscle development. J Proteome Res (2007) 0.97
14-3-3 zeta as novel molecular target for cancer therapy. Expert Opin Ther Targets (2012) 0.96
Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients. Cell Oncol (2009) 0.96
Treatment effects of twin-block and mandibular protraction appliance-IV in the correction of class II malocclusion. Angle Orthod (2010) 0.96
Stromelysin-3 expression is an early event in human oral tumorigenesis. Int J Cancer (2003) 0.95
Small interfering RNA targeting 14-3-3ζ increases efficacy of chemotherapeutic agents in head and neck cancer cells. Mol Cancer Ther (2010) 0.94
Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma. Oncology (2005) 0.94